Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.37 |
| ▸ | CACNG8 | Q8WXS5 | 3/20 | 0.37 |
| ▸ | CD44 | P16070 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 2/20 | 0.35 |
| ▸ | FABP4 | P15090 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28251645 | 0.93 | ALDH1A1 (0.37) | CYP1A2CYP2A6GRIA1CACNG8CD44 | |
| SCHEMBL27910922 | 0.84 | GRIA1 (0.42) | GRIA1CACNG8TSHRALDH1A1SRC | |
| SCHEMBL27943320 | 0.82 | CD44 (0.42) | CD44TSHRCYP3A4CA1CA2 | |
| SCHEMBL29037313 | 0.82 | TAAR1 (0.38) | TSHRHTR7 | |
| SCHEMBL2280826 | 0.82 | GABRA1 (0.46) | TSHRCA2ALDH1A1TDP1 | |
| SCHEMBL25308417 | 0.78 | TDP2 (0.38) | — | |
| SCHEMBL1070019 | 0.78 | RAPGEF4 (0.33) | CYP1A2CYP2A6ALDH1A1TDP1 | |
| SCHEMBL3534700 | 0.78 | TSHR (0.53) | TSHRACHECYP3A4CA1CA2 | |
| SCHEMBL28467302 | 0.76 | CYP2A6 (0.31) | CYP2A6 | |
| SCHEMBL9957903 | 0.76 | MEN1 (0.37) | CYP1A2HTR7ALDH1A1SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114315883-B | Dibenzofuran phenol IVB metal complex and preparation method thereof, catalyst system and olefin polymerization method | 万华化学集团股份有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-115385956-A | Biaryl diphosphine ligands and transition metal complexes thereof | 东莞市均成高新材料有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-114315883-A | Dibenzofuran phenol IVB group metal complex, preparation method thereof, catalyst system and olefin polymerization method | 万华化学集团股份有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-112358498-A | Tetraaryloxy IVB group binuclear metal complex and preparation and application thereof | 万华化学集团股份有限公司 | 2021-02-12 | — | — | CN | claimed |
| CN-112142775-A | Phenolphenanthroline IVB group metal complex and preparation and application thereof | 万华化学集团股份有限公司 | 2020-12-29 | — | — | CN | claimed |
| CN-111018923-A | Carbohydrate monophosphines, process for their preparation and their use | 东莞市均成高新材料有限公司 | 2020-04-17 | — | — | CN | claimed |
| CN-111018923-B | Carbohydrate monophosphines, method for the production and use thereof | 东莞市均成高新材料有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20240122065-A1 | METAL PATTERNING MATERIAL, AMINE COMPOUND, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN | TOSOH CORPORATION (JP) | 2024-04-11 | — | — | US | disclosed |
| EP-4342883-A1 | PHOTOELECTRIC CONVERSION ELEMENT MATERIAL FOR IMAGING ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT FOR IMAGING ELEMENT | Tosoh Corporation (JP) | 2024-03-27 | — | — | EP | disclosed |
| CN-117044428-A | Lateral current suppressing material, carbazole compound, hole injection layer, and organic electroluminescent element | 东曹株式会社 | 2023-11-10 | — | — | CN | disclosed |
| CN-114315883-B | Dibenzofuran phenol IVB metal complex and preparation method thereof, catalyst system and olefin polymerization method | 万华化学集团股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| EP-3621946-B1 | INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS | DOTTIKON ES HOLDING AG (CH) | 2023-09-06 | — | — | EP | disclosed |
| CN-110740986-B | Indane derivatives and their use in organic electronic devices | 多蒂肯独家合成控股公司 | 2023-08-25 | — | — | CN | disclosed |
| US-20100069243-A1 | Pyrimidylmethyl-Sulfonamide Compounds | BASF SE (DE) | 2010-03-18 | — | — | US | disclosed |
| CN-1561317-A | Chain extension reaction method | BP CHEM INT LTD (GB) | 2005-01-05 | — | — | CN | disclosed |
| EP-1054871-A2 | PYRIMIDINES AND TRIAZINES AS INTEGRIN ANTAGONISTS | Du Pont Pharmaceuticals Company (US) | 2000-11-29 | — | — | EP | disclosed |
| US-6060569-A | USING AS COORDINATION CATALYSTS NOVEL NICKEL COMPLEXES IN WHICH THE NICKEL IS COORDINATED TO SELECTED PHOSPHOROUS SUBSTITUTED ARYL SULFONAMIDE LIGANDS; LUBRICANTS OR IN WAXES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-05-09 | — | — | US | disclosed |
| WO-1999050249-A2 | PYRIMIDINES AND TRIAZINES AS INTEGRIN ANTAGONISTS | DU PONT PHARMACEUTICALS COMPANY (US) | 1999-10-07 | — | — | WO | disclosed |
| EP-0828737-A1 | ISOXAZOLINE AND ISOXAZOLE DERIVATIVES AS INTEGRIN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-03-18 | — | — | EP | disclosed |
| US-5710159-A | IMIDAZOLIN-2-YLAMINOPROPOXY)ISOXAZOL-5-CARBONYLAMINO-2 -BENZYLOXYCARBONYLAMINOPROPIONIC ACID AS ANTIINFLAMMATORY AGENTS, BONE DEGRADATION, TUMORS, METASTASES AND THROMBOSIS | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069243-A1 | Pyrimidylmethyl-Sulfonamide Compounds | TPMT, NISCH, PPA1 | CYP1A2 1087/4885CYP2A6 1415/4885GRIA1 3419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.